Items-$0.00
Email:sales@ruixibiotech.com
Tel.:02988811435
Bortezomib-d8
Bortezomib-d8
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-R-1261 | 1mg | 730.00 | + Add to cart |
|
| R-R-1261 | 2mg | 1230.00 | + Add to cart |
|
|
|
||||
Product description
Bortezomib-d8 is the deuterium labeled Bortezomib. Bortezomib (PS-341) is a reversible and selective proteasome inhibitor, and potently inhibits 20S proteasome (Ki=0.6 nM) by targeting a threonine residue. Bortezomib disrupts the cell cycle, induces apoptosis, and inhibits NF-κB. Bortezomib is the first proteasome inhibitor anticancer agent. Anti-cancer activity.
| Appearance | N/A |
|---|---|
| Molecular Weight | 392.29 |
| Purity | >90% |
| CAS | N/A |
| Formula | C19H17D8BN4O4 |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 2 weeks |
| Stability | 1 year |
Document
msds of Bortezomib-d8 Related Product
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com
